{"id":22310,"date":"2020-01-10T13:04:40","date_gmt":"2020-01-10T13:04:40","guid":{"rendered":"http:\/\/www.fyeo.in\/ultragenicglobal\/?page_id=22310"},"modified":"2023-04-17T10:34:02","modified_gmt":"2023-04-17T10:34:02","slug":"insights","status":"publish","type":"page","link":"https:\/\/www.fyeo.in\/ultragenic\/insights\/","title":{"rendered":"Insights"},"content":{"rendered":"
<\/div>
Insights<\/span>

\u201cA new idea comes suddenly and in a rather intuitive way. But intuition is nothing but the outcome of earlier intellectual experience.\u201d – Albert Einstein<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

<\/div>
<\/div>
Insights<\/span>

\u201cA new idea comes suddenly and in a rather intuitive way. But intuition is nothing but the outcome of earlier intellectual experience.\u201d – Albert Einstein<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

<\/div>
\"\"<\/a><\/div>
Beyond Infrastructure: Designing a Workplace That Enables Collaboration, Well-Being, and Innovation<\/a>
20 April 2026<\/span>
Creating Workplaces Where People Want to Work The role of the workplace is being redefined. Across industries, organizations are asking a fundamental question: what should an office represent in the...<\/div>View More<\/a><\/div><\/div><\/div><\/div><\/div>
\"\"<\/a><\/div>
AI won\u2019t magically transform PV<\/a>
17 April 2026<\/span>
Advocating hybrid-by-design pharmacovigilance systems - where humans and intelligent agents operate as equal actors Artificial intelligence is rapidly entering the pharmacovigilance landscape. From case intake to literature screening and signal...<\/div>View More<\/a><\/div><\/div><\/div><\/div><\/div>
\"\"<\/a><\/div>
When Control Becomes the Real Transformation in Pharmacovigilance<\/a>
03 March 2026<\/span>
Your PV System Works. But Do You Control It? Most pharmacovigilance systems run. Cases are processed. Reports are submitted. Audits are passed. On paper, everything looks stable. But here\u2019s the...<\/div>View More<\/a><\/div><\/div><\/div><\/div><\/div>
Older Post<\/span><\/i><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div>
Get Started<\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Your PV System Works. But Do You Control It? Most pharmacovigilance systems run. Cases are processed. Reports are submitted. Audits are passed. On paper, everything looks stable. But here\u2019s the uncomfortable question many PV leaders quietly wrestle with: If you cannot directly control your own safety data, do you truly own your pharmacovigilance operation? A Japan-headquartered global pharmaceutical company recently confronted this reality. Their system functioned. Processes were in place. The vendor relationship was active. Yet beneath the surface, there was growing friction \u2014 limited visibility, dependency layers, constrained access to data, and reduced agility when change was needed. What they were looking for was not a new vendor. They were looking for control. The Strategic Shift to UltraPaaS The move to UltraPaaS was not positioned as a migration project. It was framed internally as a governance decision. The objectives were clear: Full ownership of safety data Direct visibility across global and Japan operations Faster responsiveness without escalation chains Stronger alignment between system architecture and internal compliance standards The ability to scale without structural limitations This was about redesigning the power structure of their PV ecosystem. What Changed \u2014 Structurally With UltraPaaS, the balance shifted. The client gained real-time access,...","protected":false},"author":1,"featured_media":23036,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-22310","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/pages\/22310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/comments?post=22310"}],"version-history":[{"count":43,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/pages\/22310\/revisions"}],"predecessor-version":[{"id":24213,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/pages\/22310\/revisions\/24213"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/media\/23036"}],"wp:attachment":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/media?parent=22310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}